Vaughan David Investments LLC IL raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Rating) by 200.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,077 shares of the medical equipment provider’s stock after buying an additional 718 shares during the quarter. Vaughan David Investments LLC IL’s holdings in Intuitive Surgical were worth $387,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of ISRG. NN Investment Partners Holdings N.V. lifted its stake in Intuitive Surgical by 62.7% in the third quarter. NN Investment Partners Holdings N.V. now owns 40,717 shares of the medical equipment provider’s stock valued at $13,493,000 after buying an additional 15,698 shares during the period. Pictet & Cie Europe SA raised its position in shares of Intuitive Surgical by 0.7% during the third quarter. Pictet & Cie Europe SA now owns 54,478 shares of the medical equipment provider’s stock worth $54,159,000 after purchasing an additional 381 shares during the period. Creative Planning raised its position in shares of Intuitive Surgical by 1.0% during the third quarter. Creative Planning now owns 13,551 shares of the medical equipment provider’s stock worth $13,472,000 after purchasing an additional 129 shares during the period. O Shaughnessy Asset Management LLC raised its position in shares of Intuitive Surgical by 40.3% during the third quarter. O Shaughnessy Asset Management LLC now owns 2,415 shares of the medical equipment provider’s stock worth $2,402,000 after purchasing an additional 694 shares during the period. Finally, Rafferty Asset Management LLC raised its position in shares of Intuitive Surgical by 28.1% during the third quarter. Rafferty Asset Management LLC now owns 8,514 shares of the medical equipment provider’s stock worth $8,464,000 after purchasing an additional 1,870 shares during the period. 83.69% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts have recently weighed in on ISRG shares. Piper Sandler upped their target price on Intuitive Surgical from $310.00 to $316.00 and gave the stock an “overweight” rating in a research report on Friday, April 22nd. Morgan Stanley lowered their target price on Intuitive Surgical from $325.00 to $300.00 and set an “equal weight” rating on the stock in a research report on Monday, April 25th. Zacks Investment Research lowered Intuitive Surgical from a “buy” rating to a “hold” rating and set a $257.00 target price on the stock. in a research report on Wednesday, April 27th. Royal Bank of Canada initiated coverage on Intuitive Surgical in a report on Friday, March 25th. They set an “outperform” rating and a $340.00 price target for the company. Finally, BTIG Research decreased their price target on Intuitive Surgical from $372.00 to $360.00 and set a “buy” rating for the company in a report on Friday, January 21st. Eight analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Buy” and a consensus target price of $326.60.
Intuitive Surgical (NASDAQ:ISRG – Get Rating) last posted its quarterly earnings results on Thursday, April 21st. The medical equipment provider reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.07. The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.43 billion. Intuitive Surgical had a return on equity of 14.16% and a net margin of 27.84%. The firm’s quarterly revenue was up 15.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.17 EPS. Sell-side analysts expect that Intuitive Surgical, Inc. will post 4.14 earnings per share for the current year.
In other news, EVP Myriam Curet sold 6,000 shares of the stock in a transaction on Tuesday, April 26th. The stock was sold at an average price of $252.51, for a total transaction of $1,515,060.00. Following the completion of the transaction, the executive vice president now owns 361 shares in the company, valued at approximately $91,156.11. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.90% of the stock is currently owned by corporate insiders.
Intuitive Surgical Profile (Get Rating)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
- Get a free copy of the StockNews.com research report on Intuitive Surgical (ISRG)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.